키다마이드

키다마이드
키다마이드 구조식 이미지
카스 번호:
743420-02-2
한글명:
키다마이드
동의어(한글):
키다마이드
상품명:
Chidamide
동의어(영문):
CS-1764;Chidamide;HBI-8000);HDAC-IN-7;Chidamide D4;Chidamide(CS055;chidamide analog;Chidamide impurity;Chidamide USP/EP/BP;Tucidinostat (Chidamide)
CBNumber:
CB42590631
분자식:
C22H19FN4O2
포뮬러 무게:
390.41
MOL 파일:
743420-02-2.mol

키다마이드 속성

녹는점
>145°C (dec.)
끓는 점
600.2±55.0 °C(Predicted)
밀도
1.336±0.06 g/cm3(Predicted)
저장 조건
2-8°C(protect from light)
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨, 초음파처리)
물리적 상태
고체
물리적 상태
단단한 모양
산도 계수 (pKa)
12.30±0.70(Predicted)
색상
미색부터 페일 베이지까지

안전

키다마이드 C화학적 특성, 용도, 생산

개요

Chidamide (Epidaza®), a class I HDAC inhibitor, was discovered and developed by ChipScreen and approved by the CFDA in December 2014 for the treatment of recurrent of refractory peripheral T-cell lymphoma. Chidamide, also known as CS055 and HBI- 8000, is an orally bioavailable benzamide type inhibitor of HDAC isoenzymes class I 1–3, as well as class IIb 10, with potential antineoplastic activity. It selectively binds to and inhibits HDAC, leading to an increase in acetylation levels of histone protein H3.74 This agent also inhibits the expression of signaling kinases in the PI3K/ Akt and MAPK/Ras pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis. Currently, phases I and II clinical trials are underway for the treatment of non-small cell lung cancer and for the treatment of breast cancer, respectively.

용도

De-5-fluoro 4-Fluorochidamide is an analogue of Chidamide (CAS 743420-02-0), a hitsone deacetylase inhibitor (HDACI) that enhances gemcitabine (G305000) cytotoxicity in pancreatic cancer cells.

Synthesis

The scalable synthetic approach to chidamide very closely follows the discovery route. The sequence began with the condensation of commercial nicotinaldehyde (52) and malonic acid (53) in a mixture of pyridine and piperidine. Next, activation of acid 54 with N,N0-carbonyldiimidazole (CDI) and subsequent reaction with 4-aminomethyl benzoic acid (55) under basic conditions afforded amide 56 in 82% yield. Finally, activation of 56 with CDI prior to treatment with 4-fluorobenzene- 1,2-diamine (57) and subsequent treatment with TFA and THF yielded chidamide (VIII) in 38% overall yield from 52. However, no publication reported that mono-N-Boc-protected bis-aniline was used to approach Chidamide.

Synthesis_743420-02-2

키다마이드 준비 용품 및 원자재

원자재

준비 용품


키다마이드 공급 업체

글로벌( 129)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32686 60
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139
candy@biochempartner.com CHINA 967 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
WinWin Chemical CO., Limited
+86-0577-64498589 +8615325081899
sales@win-winchemical.com China 14145 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 27945 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
Coresyn Pharmatech Co., Ltd.
+86-571-86626709 +86-18157142896
cbc@coresyn.com China 9991 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3136 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054
trendseenbio@gmail.com China 11681 58

Copyright 2019 © ChemicalBook. All rights reserved